Health Care

An Aspirin a Day Won't Make Healthy Adults Live Longer, Study Shows

An Aspirin a Day Won't Make Healthy Adults Live Longer, Study Shows”

Prof John McNeil, from Monash University, said: "It means millions of healthy older people around the world who are taking low dose aspirin without a medical reason, may be doing so unnecessarily, because the study showed no overall benefit to offset the risk of bleeding".

Over a four-year span starting in 2010, the trial enrolled more than 19,000 people in Australia and the United States of America who were 70 and older, or 65 for African-American and Hispanic participants because their risks of dementia or cardiovascular disease are higher.

There is good evidence that taking aspirin can help people with known cardiovascular problems.

Aspirin has been widely used in healthy older adults to protect against cardiovascular disease and cancer. "But not only did it not decrease risk of disability or death, it did not decrease the risk of heart attack and stroke, and there was an increase in the rate of death".

So yes, don't pop aspirin if you are healthy.

Participants took either aspirin or a placebo daily over a four-and-a-half year period.

The trial followed 19,114 seniors - 2,411 from the USA and 16,703 Australians - for an average of 4.7 years.

Older patients experienced no health benefits from taking aspirin, according to the new report, published Sunday in the New England Journal of Medicine.

Undeniably the second study features that the probability of vital hemorrhage was crucially higher with aspirin as compared to placebo.

Doctor Evan Hadley, of the NIA, added: 'Continuing follow-up of the ASPREE participants is crucial, particularly since longer term effects on risks for outcomes such as cancer and dementia may differ from those during the study to date.

McNeil added that a small increase in deaths observed in the aspirin group, primarily from cancer, required further investigation as researchers can not rule out that it may be a chance finding.

One of the more unexpected findings of the study was that people who took aspirin were slightly more likely to have died over the course of the trial from any cause (5.9 percent) than those who took the placebo (5.2 percent). Patients who were black or Hispanic and living in the United States were included in the study as they face a higher risk of heart disease or dementia generally.

But a new Australian-led study has found that's not the case.

The risk is generally calculated using factors such as age, blood pressure, cholesterol levels, smoking history and other conditions such as diabetes. For people older than 70, the task force says it does not have enough information.

At the end of the study, the rate of cardiovascular disease between the two groups of participants was not much different: 9,525 of those taking the aspirin had developed cardiovascular disease compared to 9,589 of those taking the placebo.

They also attributed the higher mortality in this test group to cancer-related deaths.

Clinically significant bleeding - hemorrhagic stroke, bleeding in the brain, gastrointestinal hemorrhages or other hemorrhages that required transfusion or hospitalisation - occurred in 3.8 per cent on aspirin and in 2.7 per cent taking the placebo.

Like this



18 September 2018
Barnier talks with Spain about Gibraltar ahead of Brexit
During this time , it would be able to negotiate new free trade agreements with non-EU states. Gove said the responsibility was now with Brussels "because we've shown flexibility".

18 September 2018
Meghan Markle birthday well-wishers receive thank you cards from duchess
In an unearthed post from her now closed-down blog, The Tig, Meghan wrote about how she goes about finding the flawless gift. Meghan Markle with Misha Nonoo and Marks Anderson. "She's not fussy - she's just trying to get it on and get out the door".

18 September 2018
Lucid Motors gets $1B from Saudi fund, pushes EV debut to 2020
But previous splashy market-moving promises by the kingdom's assertive Crown Prince Mohammed bin Salman have yet to materialize. Musk indicated that Saudi Arabia would invest in Tesla if it went private, although the PIF did not comment on the possibility.

18 September 2018
The Talk: Julie Chen Officially Exits
The plan, as of this writing, is for Julie to make the announcement Tuesday morning via a taped video piece on the show. In a statement, she said she would be off for a few days, but she did not address the allegations against her husband.

18 September 2018
Asia Argento Threatens Rose McGowan with a Lawsuit
The goods on Argento were leaked by Rain Dove , McGowan's current partner. You've spent and risked a lot to stand with the MeToo movement .

18 September 2018
Focus on Hollywood’s diversity at Emmy Awards
It was an offbeat yet amusing start to the Primetime Emmys , which was unusually held on a Monday night. The Best Variety Sketch Series victory extends the late-night show's record 71 wins to 72.

18 September 2018
More volunteers from NE Ohio deployed to help with Hurricane Florence efforts
You can also volunteer to assemble relief kits for families, or donate items through the organization's Amazon Wishlist . Donations made to the Charleston Animal Society will support animal rescue efforts in the affected areas of SC .

18 September 2018
Fortnite's Port-a-Fortress offers bigger, better protection
On the Port-a-Fort, you see a one-column tower-but the Port-a-Fortress outline appears to be much wider and taller. For Fortnite's newest item, Epic seems to be taking the idea of the Port-a-Fort and making it bigger.

18 September 2018
Vermont Delegation Calls for Delay in Kavanaugh Vote
She managed to get away, and didn't speak about it to anyone until 2012, when it came up in couples therapy with her husband. Senate Minority Leader Chuck Schumer believes the judiciary committee vote for Kavanaugh needs to be delayed.

18 September 2018
Newest Tariffs On China May Spread Pain To Ordinary Households
The sensitive Australian dollar also moved up 0.4 percent to $0.7212 having also initially been hit when the tariff details broke. But the adjustments did little to appease technology and retail groups who argued that the tariffs would hit consumers hard.